The Rpn13 protein, previously termed adhesion-regulating protein 1 or GP110, has been identified as a tumor-associated gene product [1], [2], [3], [4], [5], [6], and more recently as an amplification target in ovarian cancer [7]. The gene discussed is ADRM1; the disease is ovarian carcinoma.